17,483.051
0.006 BRL
4.92 B BRL
11.63 B BRL
About United Therapeutics Corporation
Sector
CEO
Martine A. Rothblatt
Headquarters
Silver Spring
Website
Founded
1996
ISIN
BRU2THBDR002
FIGI
BBG01HH22HD4
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where U2TH34 is featured.